ANTHEM
Anthem Biosciences Limited
Biotechnology
Share price
₹871
Market cap
₹49,101 Cr
1Y return
▲ 3%
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
Investors holding Anthem Biosciences Limited
1.47%
Latest move
Axis Mutual FundNew position
Axis Mutual Fund newly entered Anthem Biosciences, acquiring 6,686,210 shares for a 1.19% stake, worth ₹519.53 Cr at ₹777 apiece.
Sign in to read more
Whales made 23 more moves in Anthem Biosciences Limited
Sign in to see who is buying and selling.
Sign in to find out